News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Phogen Ltd Enters Into Technology Commercialisation Agreement With Cancer Research Technology



10/19/2005 5:09:04 PM

Cambridge, UK, 1 August 2005 Phogen Ltd ("Phogen") and Cancer Research Technology Limited (CRT) announce today that they have entered into an exclusive Technology Commercialisation Agreement for the commercialisation of Phogen’s VP22 technology.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES